There is a lack of data on the burden of atopic dermatitis (AD) in adults relative to the general population.Objective:
To characterize the AD burden in adult patients relative to both matched non-AD controls and matched patients with psoriasis in terms of comorbidities, health care resource utilization (HCRU), and costs.Methods:
Adults (≥18 years) who self-reported a diagnosis of AD or psoriasis and adult non-AD controls were identified from the 2013 US National Health and Wellness Survey. Patients with AD were propensity score–matched with non-AD controls and patients with psoriasis on demographic variables. Patient-reported outcomes were analyzed between matched cohorts.Results:
Patients with AD had a significantly greater risk for atopic comorbidities, as well as significantly greater HCRU and total cost compared with non-AD controls. The burden of AD was generally comparable to that of psoriasis, although patients with AD reported increased use of emergency room visits compared with patients with psoriasis.Limitations:
Patient-reported data are susceptible to recall bias and erroneous classification.Conclusions:
Adult patients with AD reported a substantial disease burden, suggesting an unmet need for more effective AD treatment options.